Analytics
Signs are everywhere that healthcare is finally starting to see the transformative potential of analytics, just as many other industries have for years. Nonetheless, "there are a lot of challenges. And part of that is just: 'Who's going to do the heavy lifting on this?'"
HHS could soon release a big collection of data, twice as much as it has in the past, according to a report from Medical Practice Insider.
An increasing number of babies across the country are born addicted to opioids and require intensive care, according to a study analyzing MEDNAX Clinical Data Warehouse statistics from 299 neonatal intensive care units across the country.
IBM Watson Health is collaborating with Epic and Mayo Clinic to apply cognitive computing capabilities of Watson to EHRs, and also with 14 cancer institutions to reduce from weeks to minutes the ability to translate DNA insights.
Cleveland Clinic is the latest world-class provider to make its analytics algorithms available on Apervita, enabling other health providers to put some of its knowledge to work improving their own outcomes.
IBM announced Monday it had completed the acquisition of Dallas-based population health company Phytel. Financial terms of the deal were not disclosed.
Conversations at HIMSS conferences in recent years have been largely dominated by meaningful use. This year, a great deal of talk was about going past MU and beginning to look at outcomes as opposed to process measures.
With $9.75 million in hand from gifts and matching funds, Duke University is launching an initiative focused on harnessing vast amounts of data to tackle society's biggest challenges. Healthcare is chief among them.
There's a problem in the world of data analytics. A new survey of health IT professionals shows that the lion's share of them see clinical and business intelligence as top priorities for 2015, but the majority also say they don't even know what data to actually collect.
The FDA is offering a grant of up to $1 million to turn large amounts of EHR data into numbers the agency can use to gauge the effectiveness of FDA-approved drugs.